Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vivoryon Therapeutics N.V. sell Lokrim

Start price
€4.61
27.05.24 / 20%
Target price
-
27.05.25
Performance (%)
-62.73%
End price
€1.72
28.05.25
Summary
This prediction ended on 28.05.25 with a price of €1.72. The SELL prediction by Lokrim for Vivoryon Therapeutics N.V. performed very well with a performance of -62.73%. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vivoryon Therapeutics N.V. 0.893% 0.893% -21.853%
iShares Core DAX® -1,28 % 4,21 % 7,08 %
iShares Nasdaq 100 -3,34 % -1,74 % 26,18 %
iShares Nikkei 225® -4,29 % -1,62 % 44,32 %
iShares S&P 500 -2,31 % -0,10 % 20,82 %

According to Lokrim what are the pros and cons of Vivoryon Therapeutics N.V. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Vivoryon Therapeutics AG diskutieren

Sell Vivoryon Therapeutics N.V.

In the thread Trading Vivoryon Therapeutics AG
Prediction Sell
Perf. (%) -62.73%
Target price
Change
Ends at 27.05.25

Die von Lokrim gewählte maximale Laufzeit wurde überschritten